AAPG (Ascentage Pharma Group International) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AAPG Ascentage Pharma Group International AAPG
57 GF Score
Price $19.24
GF Value $22.94
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Ascentage Pharma Group International Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

AAPG vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Ascentage Pharma Group International's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascentage Pharma Group International Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's Short Interest distribution charts can be found below:

* The bar in red indicates where Ascentage Pharma Group International's Short Interest falls into.


AAPG
57GF Score
Ascentage Pharma Group International AAPG
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ascentage Pharma Group International (AAPG) Overvalued in 2026?

Based on GuruFocus' analysis, Ascentage Pharma Group International stock appears to be undervalued. The current stock price of $19.24 is trading 16.1% below its estimated GF Value™ of $22.94. GuruFocus considers Ascentage Pharma Group International to be Modestly Undervalued.

Key valuation signals for AAPG:

  • Short Interest:
  • GF Value™: $22.94 vs. price of $19.24 (16.1% below fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the AAPG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ascentage Pharma Group International Business Description

Address 68 Xinqing Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215000
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
57GF Score

Get the complete analysis for AAPG

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.24
Price
$22.94
GF Value